Background
==========

The advent of the HIV pandemic and the more recent prevention and therapeutic interventions have resulted in extensive and rapid changes in cause-specific mortality rates in sub-Saharan Africa during the last two decades \[[@B1]-[@B3]\]. South Africa, in particular, with a severe HIV epidemic, experienced a steep rise in adult mortality during the 1990s and the early part of this decade \[[@B4],[@B5]\] and is one of few countries where child mortality increased from the 1990 baseline \[[@B6]\]. In the past few years, evidence is emerging from South Africa \[[@B7],[@B8]\] and elsewhere in sub-Saharan Africa \[[@B9]-[@B12]\] that HIV-related mortality is declining following the introduction of prevention and treatment programs. In South Africa, these changes have occurred against the backdrop of a steadily increasing noncommunicable disease burden \[[@B13]\] and high trauma-related mortality \[[@B14]\]. With limited reliable data as to whether HIV-related health care is flourishing to the detriment of non-HIV care, there is demand for timely and accurate cause-specific mortality data to steer public health responses and to evaluate the outcome of interventions \[[@B15]\].

Due to the lack of death registration systems in the majority of the world\'s poorest settings, verbal autopsy-based mortality surveillance has become one of the methods of choice to obtain the much needed cause-specific mortality data \[[@B15]\]. In particular, health and demographic surveillance sites have a role to play in this context to provide timely and accurate data \[[@B16]\]. Although South Africa has a functioning death registration system, the quality of cause of death data has been questioned \[[@B17],[@B18]\] and data from demographic surveillance studies using verbal autopsies have contributed to determining cause-specific mortality rates \[[@B19]-[@B21]\] in the country.

Verbal autopsy (VA) methods have traditionally depended on physician assessment of the verbal autopsy interview data to determine a cause of death \[[@B22]\], but the efficiency, reliability, and repeatability of this approach have recently been questioned \[[@B22],[@B23]\]. Alternative methods to determine the cause of death on the basis of a verbal autopsy interview have been developed \[[@B22],[@B24]\], such as the InterVA (<http://www.interva.net>) system, which applies Bayes\' theorem to derive probable causes of death from VA data \[[@B25]\].

Using data from a well-established longitudinal demographic surveillance, this study describes cause-specific mortality trends based on verbal autopsies conducted on all deaths in a rural population in KwaZulu-Natal, South Africa, over a 10-year period (2000-2009).

Methods
=======

Study area and population
-------------------------

The Africa Centre for Health and Population Studies hosts a demographic surveillance program in the district of Umkhanyakude in the province of KwaZulu-Natal, South Africa \[[@B26]\]. Although it is largely rural, the demographic surveillance area (DSA), consisting of 435 square kilometers, also includes a township and periurban informal settlements. The population is characterized by high HIV prevalence \[[@B27]\] and incidence \[[@B28]\], but following the introduction of prevention of mother-to-child transmission of HIV infection (in 2001) and antiretroviral treatment and care (in 2004) programs, child \[[@B8]\] and adult \[[@B7]\] all-cause mortality have started to decline. The study population has comparatively high levels of cardiovascular risk factors \[[@B29]\] and high trauma-related mortality \[[@B30]\].

Mortality data
--------------

The approximately 12,000 households in the DSA were visited thrice annually by fieldwork teams and all deaths were notified. Upon death notification, a trained nurse conducted an interview with the closest caregiver (parent or grandparent, 26%; spouse, child, or grandchild, 25%; other relative, 20%; sibling, 14%) of the deceased on average six months after the death. The nurses recorded a narrative of the circumstances leading up to the death and completed a questionnaire based on the standard INDEPTH/WHO verbal autopsy questionnaire \[[@B31],[@B32]\]. Interviews were conducted in the local language and transcribed by the interviewer, after verbal consent. There were 228 (2%) refusals and 102 (0.9%) cases where a suitable interviewee could not be identified. A total of 13 nurses acted as interviewers over the course of the study; 80% of the interviews were conducted by six of these nurses. The majority of the nurses were graduate professional nurses; the remainder had two-year nursing diplomas. All were previously employed with local health services and received training in administering the verbal autopsy questionnaire.

Two methods were used to determine cause of death for each case: physician coding and an automated method using the InterVA v3 probabilistic verbal autopsy interpretation model. In the physician-coded method, two clinicians independently assigned cause of death on the basis of the information collected during the verbal autopsy and their clinical judgement. If consensus could not be reached between the physicians, the VA interview was refused, or no suitable interviewee could be found, the cause of death was recorded as \"undetermined.\" A third clinician reviewed all cases and codified the causes of death using the International Classification of Diseases, 10^th^revision (ICD-10)\[[@B33]\]. The ICD-10 codes were mapped into global burden of disease groups (Table [1](#T1){ref-type="table"}) using the crosswalk in Lopez \[[@B34]\]. A total of 27 physicians were involved over the course of the study period (2000 to 2009) in assigning diagnoses, however, eight physicians were responsible for 79% of the recorded diagnoses. Complete cause of death coding for the physician-coded diagnoses was available for deaths between 2000 and the end of 2008.

###### 

Burden of disease groups

  Cause category                                            Abbreviation    Burden of disease codes
  --------------------------------------------------------- --------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  HIV-related causes                                        HIV-related     U003, U009
                                                                            
  Other communicable diseases                               Other CD        U005, U007, U008, U010, U015, U016, U017, U018, U020, U033, U037, U039
                                                                            
  Maternal, perinatal, nutritional, and congenital causes   MPNC            U042, U043, U044, U045, U047, U048, U050, U051, U052, U054, U131, U136, U139, U140, U142
                                                                            
  Noncommunicable lifestyle-related conditions              Lifestyle       U079, U105, U106, U107, U108, U109, U110, U112, U113, U114, U116, U117, U119, U120, U121, U122, U123
                                                                            
  Other noncommunicable conditions                          Other NCD       U059, U060, U061, U062, U063, U064, U065, U067, U068, U069, U070, U071, U072, U073, U074, U075, U076, U077, U078, U080, U081, U082, U084, U085, U086, U087, U096, U097, U124, U125, U130
                                                                            
  Injuries                                                  Injuries        U148, U150, U151, U152, U153, U154, U155, U157, U158
                                                                            
  Indeterminate causes                                      Indeterminate   U000, Z900, Z993, Z994, Z997, Z998, Z999

The InterVA model is based on Bayesian calculations of probabilities that a particular death was due to particular causes, given a set of symptoms and circumstances associated with the death \[[@B25]\]. The verbal autopsy questionnaire data were converted into the 106 input indicators required by the InterVA probabilistic model using an SQL script. Cause of death categories were obtained by running InterVA in batch mode on the input indicators with malaria prevalence set to \"low\" and HIV prevalence set to \"high.\" The 35 possible InterVA cause categories were mapped to the corresponding burden-of-disease codes to have cause categories comparable to the physician-coded diagnoses. InterVA produced up to three possible causes of death per case with a likelihood value between 0 and 1 for each cause. In cases where the likelihood values did not sum to 1 for a particular case, the difference between the sum of the likelihood values for the identified causes and 1 were allocated to the \"indeterminate\" cause. As recommended by the developers of InterVA, all identified causes were considered proportionate to their likelihood values in the rate calculations.

Data analysis
-------------

Deaths and person-years of observation were aggregated annually for the period from Jan. 1, 2000, to Dec. 31, 2009, for all individuals in the study population.

Individuals contributed to the person-years denominator from Jan. 1, 2000, or from any later date of birth or in-migration, until Dec. 31, 2009, and they ceased to contribute to the denominator at death, termination of household membership, household out-migration, or the last surveillance visit in which household membership was confirmed. Thus, individuals who were previous homestead residents continued to be followed when they became nonresidents for as long as they remained a member of (retained links with) the household under surveillance. Out-migrants continued to be followed as nonresident household members in 83% of emigrations over the duration of the study.

We stratified mortality analysis by five age groups (under 5, 5-14, 15-49, 50-64, and over 65 years). The age-group boundaries were chosen to separate groups of public health importance and different patterns of mortality. There were no major changes in age group composition over the course of the study, and age-standardized mortality rates did not differ significantly on a year-to-year basis, therefore crude mortality rates are reported throughout. Under-5 mortality rates were expressed as deaths per person-years observed, rather than the customary deaths per live births, for consistent comparison to the mortality rates in the other age groups. Exact Poisson confidence intervals were calculated for all-cause mortality rates and cause-specific mortality rates and fractions where those were based on the single-cause physician-coded causes \[[@B35]\]. Confidence intervals for cause-specific mortality rates and fractions in the case of the InterVA-coded causes were calculated with R \[[@B36]\] using bootstrapping. Cause-specific mortality rates and fractions were based on the InterVA-determined causes unless otherwise stated. The kappa analysis was done using STATA v11 \[[@B37]\].

Ethical approval for the Africa Centre Demographic Surveillance was provided by the University of KwaZulu-Natal Bio-Medical Research Ethics Committee.

Results
=======

Mortality
---------

There were 11,281 deaths over 784,274 person years of observation of 125,658 individuals between Jan. 1, 2000 and Dec. 31, 2009 (Table [2](#T2){ref-type="table"}). All causes of death were coded using InterVA; the 10,267 deaths between Jan. 1, 2000 and Dec. 31, 2008, were physician-coded as well. All-cause age-standardized mortality (SMR) for the total population changed from 139 (95% CI: 130, 148) deaths per 10,000 person-years observed (PYO) in 2000 to a maximum of 174 (95% CI: 165, 183) in 2003 and then declined to 116 (95% CI: 109, 123) in 2009 (Figure [1](#F1){ref-type="fig"}). HIV-related causes were responsible for 50% of the deaths over the period from 2000 to 2009, followed by indeterminate causes at 18% and lifestyle-related noncommunicable diseases at 15% of all deaths. HIV-related causes were responsible for a maximum 56% of deaths in 2002, declining to a minimum of 39% of deaths in 2009. Indeterminate causes were responsible for a minimum of 14% of deaths during 2000, rising to a maximum of 25% in 2009.

###### 

Person-years observed, number of deaths, and sum of InterVA likelihood values per cause of death by age group and year

  0-4 yr         PYO       Deaths       HIV-related       MPNC       Injuries       Lifestyle       Other NCD       Other CD       Indeterminate
  -------------- --------- ------------ ----------------- ---------- -------------- --------------- --------------- -------------- -------------------
  2000           9,304     185          93.7              9.2        2.4            0.3             \-              40.5           38.9
  2001           9,761     202          95.4              10.2       0.7            2.4             \-              57.4           35.9
  2002           9,969     216          87.5              13.7       5.5            \-              \-              64.8           44.5
  2003           9,806     201          71.3              4.1        1.7            1.9             \-              60.3           61.8
  2004           9,837     140          38.1              4.9        1.9            \-              \-              30.0           65.1
  2005           9,939     141          38.0              3.5        0.7            \-              \-              47.6           51.1
  2006           10,127    118          35.5              4.2        1.9            0.6             0.8             48.6           25.5
  2007           10,508    109          36.0              3.8        2.3            0.7             \-              39.9           26.3
  2008           10,539    118          28.6              4.7        3.0            0.7             \-              53.9           27.1
  2009           10,483    102          12.2              1.0        3.2            0.5             \-              50.8           34.4
                                                                                                                                   
  **5-14 yr**    **PYO**   **Deaths**   **HIV-related**   **MPNC**   **Injuries**   **Lifestyle**   **Other NCD**   **Other CD**   **Indeterminate**
                                                                                                                                   
  2000           19,642    22           3.2               \-         6.8            1.7             1.4             4.7            4.3
  2001           20,723    31           13.7              \-         4.5            2.6             0.1             4.6            5.5
  2002           21,710    35           13.0              \-         4.0            1.0             1.6             8.6            6.9
  2003           22,218    41           14.2              \-         10.5           2.2             0.6             2.8            10.7
  2004           22,416    49           25.5              \-         10.6           3.0             \-              1.6            8.4
  2005           22,181    38           18.1              \-         6.9            2.7             \-              1.3            8.9
  2006           22,052    33           15.7              \-         2.8            1.0             0.7             5.4            7.4
  2007           22,078    27           11.8              \-         4.5            0.6             \-              4.7            5.5
  2008           21,697    36           8.3               \-         9.2            2.0             1.8             4.1            9.7
  2009           21,288    22           12.9              \-         3.2            0.2             \-              1.6            4.1
                                                                                                                                   
  **15-49 yr**   **PYO**   **Deaths**   **HIV-related**   **MPNC**   **Injuries**   **Lifestyle**   **Other NCD**   **Other CD**   **Indeterminate**
                                                                                                                                   
  2000           28,618    441          327.4             4.1        34.9           32.3            0.3             5.2            36.8
  2001           32,154    547          394.0             2.4        56.1           30.7            2.2             9.7            52.0
  2002           35,475    625          485.4             2.6        44.2           29.5            3.2             6.6            53.5
  2003           37,350    701          523.1             5.8        55.2           28.1            7.2             10.2           71.5
  2004           39,059    694          480.6             3.1        81.2           26.3            5.1             4.3            93.3
  2005           40,277    647          438.2             5.2        60.2           29.9            7.2             6.4            100.1
  2006           41,826    580          375.6             2.1        73.2           26.2            3.3             7.4            92.3
  2007           43,399    624          413.2             4.7        62.3           28.5            3.4             6.9            105.1
  2008           44,235    509          294.6             1.8        85.4           23.7            6.3             4.9            92.3
  2009           45,236    495          274.2             4.7        73.3           26.0            6.3             6.1            104.6
                                                                                                                                   
  **50-64 yr**   **PYO**   **Deaths**   **HIV-related**   **MPNC**   **Injuries**   **Lifestyle**   **Other NCD**   **Other CD**   **Indeterminate**
                                                                                                                                   
  2000           4,325     124          49.3              \-         10.8           36.4            4.4             3.5            19.6
  2001           4,433     153          62.6              \-         14.2           49.2            4.3             3.9            18.9
  2002           4,553     125          60.7              \-         4.2            40.0            1.1             2.8            16.3
  2003           4,666     159          70.0              \-         8.1            46.5            8.4             2.8            23.3
  2004           4,735     136          64.1              \-         3.0            30.5            6.5             3.4            28.5
  2005           4,714     167          84.8              \-         5.9            35.6            8.2             2.7            29.8
  2006           4,715     164          60.7              \-         7.8            43.1            6.6             4.7            41.2
  2007           4,836     169          74.2              \-         5.0            41.6            3.3             2.9            41.9
  2008           4,990     155          55.7              \-         7.0            45.5            9.6             3.7            33.5
  2009           5,152     174          62.1              \-         6.8            46.7            10.8            4.2            43.5
                                                                                                                                   
  **65+ yr**     **PYO**   **Deaths**   **HIV-related**   **MPNC**   **Injuries**   **Lifestyle**   **Other NCD**   **Other CD**   **Indeterminate**
                                                                                                                                   
  2000           3,059     139          28.4              1.6        2.8            64.0            4.3             8.0            29.9
  2001           3,134     196          24.8              1.9        3.6            98.3            7.7             13.4           46.3
  2002           3,170     226          34.8              2.8        8.9            103.8           14.2            7.9            53.5
  2003           3,187     216          31.7              1.6        5.2            102.2           12.1            12.2           51.0
  2004           3,268     202          33.2              2.5        10.1           92.8            5.8             9.1            48.5
  2005           3,396     198          36.0              \-         6.1            74.2            15.9            8.0            57.8
  2006           3,494     197          30.2              1.8        8.7            77.1            13.2            7.1            59.0
  2007           3,526     229          42.6              0.7        8.8            100.6           10.1            3.8            62.4
  2008           3,539     212          25.3              0.4        9.8            104.7           6.0             5.7            60.1
  2009           3,474     211          28.0              1.1        5.9            100.6           10.4            3.3            61.7
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The largest proportion (52%) of deaths occurred in the 15-49 age group followed by the 65 and older age group at 18%. The under-5 age group contributed 20% of the deaths in 2000, but this declined to between 9% and 11% from 2007 to 2009. Overall, 82% of all deaths occurred before the age of 65 years, declining from a high of 85% in 2000 to 79% in 2009 (Figure [2](#F2){ref-type="fig"}).
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The under-5 all-cause SMR peaked at 217 (95% CI: 189, 245) deaths per 10,000 PYO in 2002 and then declined rapidly to 103 (95% CI: 83,103) in 2009 (Figure [3](#F3){ref-type="fig"}). This is greater than a twofold decline in mortality. HIV-related mortality (Table [3](#T3){ref-type="table"}) in this age group had a high in 2000 of 101 deaths per 10,000 PYO (95% CI: 86,115), plateaued at around 37 deaths per 10,000 PYO between 2004 and 2007, and then declined further to a low of 12 (95% CI: 6, 17) in 2009. Other communicable disease SMR varied between 31 (95%: CI 22, 38) in 2004 and 65 (95% CI: 54, 76) deaths per 10,000 PYO in 2002. Mortality due to indeterminate causes was high in this age group varying around 41 deaths per 10,000 PYO and peaked around 60 deaths per 10,000 between 2003 and 2005. The cause-specific mortality fraction (CSMF) due to HIV-related causes declined from 51% (95% CI: 44, 58) in 2000 to 12% (95% CI: 6, 17) in 2009. As a result of the overall decline in the mortality rate in this age group, the CSMF for other communicable diseases increased from 22% (95% CI: 17, 27) in 2000 to 50% (95% CI: 42, 57) in 2009. The all-cause SMR for the 5-14 age group peaked at 22 (95% CI: 16, 28) deaths per 10,000 PYO in 2004 and then declined to 10 (95% CI: 6, 15) in 2009 (Figure [4](#F4){ref-type="fig"}).

![**\< 5 yr Age Standardized Mortality**. (Deaths 1, 531, Person Years Observed (PYO) 100, 274).](1478-7954-9-47-3){#F3}

###### 

Cause-specific mortality rates by age group and year (per 10,000 person years observed)

  2000            0-4 yrs (95% CI)       5-14 yrs (95% CI)       15-49 yrs (95% CI)        50-64 yrs (95% CI)       65+ (95% CI)
  --------------- ---------------------- ----------------------- ------------------------- ------------------------ ---------------------
  HIV-related     100.8 (88.1-113.9)     1.6 (0.0-3.1)           114.3 (109.1-119.5)       113.8 (89.5-137.0)       94.3 (65.6-122.2)
  MPNC            8.0 (2.8-12.9)         \-                      1.4 (0.1-2.5)             \-                       3.9 (0.0-7.6)
  Injuries        2.6 (0.0-5.2)          3.5 (1.4-5.3)           11.9 (8.2-15.6)           24.4 (9.6-36.7)          9.3 (0.0-16.8)
  Lifestyle       0.3 (0.0-0.7)          0.9 (0.0-1.8)           11.1 (7.6-14.4)           83.8 (62.8-103.7)        211.2 (180.8-240.9)
  Other NCD       \-                     0.7 (0.0-1.4)           0.2 (0.0-0.5)             11.1 (2.6-18.0)          18.1 (3.8-29.5)
  Other CD        45.0 (35.4-54.5)       2.4 (0.3-4.2)           1.6 (0.3-2.7)             5.5 (0.0-11.5)           22.0 (11.0-32.8)
  Indeterminate   42.1 (33.7-49.1)       2.2 (1.2-3.0)           13.4 (11.1-15.6)          48.2 (35.9-59.0)         95.6 (78.0-113.6)
                                                                                                                    
  **2001**        **0-4 yrs (95% CI)**   **5-14 yrs (95% CI)**   **15-49 yrs (95% CI)**    **50-64 yrs (95% CI)**   **65+ (95% CI)**
                                                                                                                    
  HIV-related     97.7 (84.6-110.8)      6.6 (4.4-9.1)           122.9 (116.9-128.9)       143.9 (118.4-170.3)      77.3 (50.9-102.3)
  MPNC            10.0 (4.1-15.2)        \-                      0.4 (0.0-0.9)             \-                       6.1 (0.0-12.2)
  Injuries        0.7 (0.0-1.4)          2.2 (0.4-3.7)           17.2 (12.5-21.5)          31.9 (15.7-47.4)         10.3 (0.0-19.3)
  Lifestyle       2.5 (0.1-4.5)          1.5 (0.0-2.7)           9.9 (6.5-12.6)            111.4 (87.4-135.0)       324.3 (283.6-365.0)
  Other NCD       \-                     0.1 (0.0-0.1)           0.8 (0.0-1.5)             9.7 (1.1-16.6)           24.4 (8.5-38.4)
  Other CD        59.2 (46.6-70.2)       2.2 (0.4-3.6)           2.9 (1.0-4.6)             7.2 (0.0-12.9)           38.2 (21.3-54.6)
  Indeterminate   36.9 (29.3-43.0)       2.5 (1.3-3.4)           15.9 (13.4-18.2)          41.1 (28.8-52.3)         144.8 (121.5-168.7)
                                                                                                                    
  **2002**        **0-4 yrs (95% CI)**   **5-14 yrs (95% CI)**   **15-49 yrs (95% CI)**    **50-64 yrs (95% CI)**   **65+ (95% CI)**
                                                                                                                    
  HIV-related     87.7 (74.6-101.9)      5.9 (3.6-8.3)           137.1 (132.1-142.0)       134.7 (111.5-156.7)      106.8 (73.3-138.1)
  MPNC            12.8 (6.3-18.0)        \-                      0.7 (0.0-1.5)             \-                       8.8 (0.9-15.1)
  Injuries        5.5 (1.3-9.2)          1.8 (0.0-3.4)           12.0 (8.5-15.3)           7.8 (0.0-14.3)           26.3 (9.0-41.1)
  Lifestyle       \-                     0.5 (0.0-1.0)           8.3 (5.2-10.9)            88.0 (66.2-108.8)        341.3 (298.3-388.4)
  Other NCD       \-                     0.7 (0.0-1.5)           0.9 (0.0-1.7)             2.4 (0.0-4.9)            46.9 (27.1-65.0)
  Other CD        65.6 (54.5-76.9)       4.0 (1.9-5.8)           1.8 (0.4-3.0)             5.5 (0.0-10.6)           22.7 (7.9-35.8)
  Indeterminate   45.0 (37.4-51.7)       3.2 (1.7-4.4)           15.3 (13.0-17.6)          36.2 (23.9-46.9)         160.3 (132.6-187.5)
                                                                                                                    
  **2003**        **0-4 yrs (95% CI)**   **5-14 yrs (95% CI)**   **15-4 9 yrs (95% CI)**   **50-64 yrs (95% CI)**   **65+ (95% CI)**
                                                                                                                    
  HIV-related     72.7 (58.6-85.8)       6.4 (3.8-8.9)           140.6 (135.7-145.5)       148.2 (123.6-172.4)      99.3 (67.9-126.6)
  MPNC            4.1 (0.2-7.4)          \-                      1.4 (0.0-2.4)             \-                       5.0 (0.0-9.6)
  Injuries        1.8 (0.0-3.5)          4.8 (2.5-7.0)           13.8 (10.4-17.1)          17.4 (3.6-27.5)          16.3 (0.8-28.0)
  Lifestyle       1.9 (0.0-3.6)          0.9 (0.0-1.8)           8.3 (5.8-10.7)            105.5 (81.3-127.6)       330.0 (292.1-369.7)
  Other NCD       \-                     0.3 (0.0-0.6)           1.9 (0.6-3.1)             18.4 (7.4-28.2)          39.6 (18.2-58.8)
  Other CD        61.6 (49.5-73.0)       1.3 (0.1-2.3)           2.7 (1.2-4.1)             5.0 (0.0-9.6)            31.3 (16.0-44.9)
  Indeterminate   62.9 (51.6-73.0)       4.9 (2.9-6.6)           18.9 (16.6-21.1)          46.3 (36.7-55.4)         156.2 (131.2-181.2)
                                                                                                                    
  **2004**        **0-4 yrs (95% CI)**   **5-14 yrs (95% CI)**   **15-49 yrs (95% CI)**    **50-64 yrs (95% CI)**   **65+ (95% CI)**
                                                                                                                    
  HIV-related     38.7 (27.8-49.1)       11.4 (8.7-14.3)         123.8 (118.5-129.4)       130.7 (111.0-151.6)      100.9 (71.1-129.3)
  MPNC            4.6 (0.3-7.9)          \-                      0.8 (0.0-1.5)             \-                       6.3 (0.0-11.2)
  Injuries        1.9 (0.0-3.8)          4.8 (2.3-6.9)           20.1 (15.9-23.8)          6.3 (0.0-12.5)           24.2 (8.9-39.0)
  Lifestyle       \-                     1.3 (0.0-2.6)           6.8 (4.7-9.0)             71.8 (53.4-88.5)         302.2 (266.5-337.7)
  Other NCD       \-                     \-                      1.3 (0.3-2.2)             13.8 (4.3-21.7)          18.4 (4.7-30.4)
  Other CD        30.5 (23.0-38.9)       0.7 (0.0-1.4)           1.0 (0.2-1.7)             5.2 (0.0-9.4)            19.8 (8.0-29.9)
  Indeterminate   66.6 (55.9-76.7)       3.6 (1.8-5.2)           23.9 (20.5-27.2)          59.6 (45.6-72.5)         146.1 (122.4-169.3)
                                                                                                                    
  **2005**        **0-4 yrs (95% CI)**   **5-14 yrs (95% CI)**   **15-49 yrs (95% CI)**    **50-64 yrs (95% CI)**   **65+ (95% CI)**
                                                                                                                    
  HIV-related     38.3 (29.5-46.9)       8.2 (5.3-10.9)          108.9 (103.7-114.6)       179.4 (154.0-201.9)      104.3 (74.4-131.6)
  MPNC            3.6 (0.2-6.3)          \-                      1.2 (0.3-2.0)             \-                       \-
  Injuries        0.7 (0.0-1.4)          3.1 (1.1-5.0)           14.5 (11.0-17.5)          12.5 (2.0-21.0)          17.8 (3.9-30.0)
  Lifestyle       \-                     1.2 (0.0-2.4)           7.9 (5.3-10.2)            78.7 (59.2-97.4)         232.4 (199.1-264.9)
  Other NCD       \-                     \-                      1.8 (0.8-2.7)             17.6 (5.7-27.3)          52.3 (30.9-73.2)
  Other CD        47.9 (38.7-57.3)       0.6 (0.0-1.2)           1.5 (0.5-2.4)             4.0 (0.0-7.4)            17.8 (4.6-27.8)
  Indeterminate   51.4 (43.0-58.6)       4.0 (2.1-5.9)           24.8 (21.2-27.9)          62.1 (46.8-76.9)         158.3 (130.4-183.0)
                                                                                                                    
  **2006**        **0-4 yrs (95% CI)**   **5-14 yrs (95% CI)**   **15-49 yrs (95% CI)**    **50-64 yrs (95% CI)**   **65+ (95% CI)**
                                                                                                                    
  HIV-related     35.1 (26.2-42.8)       7.1 (5.0-9.5)           89.8 (84.8-95.0)          126.8 (104.5-149.4)      86.8 (57.1-111.7)
  MPNC            4.1 (0.0-7.6)          \-                      0.5 (0.0-0.9)             \-                       4.7 (0.0-8.7)
  Injuries        1.8 (0.0-3.7)          1.3 (0.0-2.5)           16.8 (12.7-20.5)          14.9 (2.0-24.4)          24.9 (7.5-38.5)
  Lifestyle       0.6 (0.0-1.2)          0.4 (0.0-1.0)           6.2 (4.2-8.1)             95.0 (74.9-114.4)        224.2 (190.7-257.3)
  Other NCD       0.8 (0.0-1.6)          0.3 (0.0-0.7)           0.8 (0.0-1.4)             13.9 (4.2-21.4)          39.4 (21.0-57.1)
  Other CD        47.9 (38.9-56.6)       2.5 (0.7-3.8)           1.5 (0.5-2.3)             9.5 (2.4-15.2)           18.1 (8.1-27.6)
  Indeterminate   26.2 (20.5-31.8)       3.8 (1.3-5.7)           23.0 (19.9-26.2)          87.7 (73.2-102.6)        165.8 (140.4-189.7)
                                                                                                                    
  **2007**        **0-4 yrs (95% CI)**   **5-14 yrs (95% CI)**   **15-49 yrs (95% CI)**    **50-64 yrs (95% CI)**   **65+ (95% CI)**
                                                                                                                    
  HIV-related     34.3 (25.1-42.8)       5.4 (3.3-7.5)           95.4 (91.1-100.3)         153.4 (130.8-177.3)      116.3 (85.5-144.9)
  MPNC            3.0 (0.0-5.5)          \-                      1.4 (0.2-2.3)             \-                       2.0 (0.0-4.3)
  Injuries        2.2 (0.0-4.1)          2.0 (0.4-3.5)           13.7 (10.4-16.8)          10.4 (1.1-18.1)          24.1 (10.0-36.3)
  Lifestyle       0.7 (0.0-1.5)          0.3 (0.0-0.6)           6.4 (4.3-8.4)             88.9 (66.7-109.4)        296.1 (261.9-328.5)
  Other NCD       \-                     \-                      0.8 (0.1-1.4)             5.6 (0.0-10.1)           29.5 (14.4-42.7)
  Other CD        38.6 (29.9-47.2)       2.1 (0.2-3.7)           1.6 (0.6-2.5)             4.3 (0.0-8.2)            8.3 (1.3-14.3)
  Indeterminate   25.1 (19.9-30.4)       2.5 (0.8-3.9)           24.5 (20.9-27.5)          86.9 (68.2-103.5)        173.3 (144.5-199.4)
                                                                                                                    
  **2008**        **0-4 yrs (95% CI)**   **5-14 yrs (95% CI)**   **15-49 yrs (95% CI)**    **50-64 yrs (95% CI)**   **65+ (95% CI)**
                                                                                                                    
  HIV-related     27.1 (18.5-35.7)       3.8 (1.6-6.0)           66.9 (62.4-72.1)          111.7 (89.1-134.3)       70.5 (46.9-93.4)
  MPNC            4.4 (0.5-7.6)          \-                      1.0 (0.1-1.8)             \-                       0.3 (0.0-0.7)
  Injuries        2.8 (0.0-5.1)          4.2 (1.9-6.4)           18.7 (14.7-22.4)          14.7 (2.1-24.6)          27.7 (10.8-41.2)
  Lifestyle       0.7 (0.0-1.5)          0.9 (0.0-1.9)           5.3 (3.4-7.1)             96.7 (77.8-116.4)        295.6 (260.9-333.1)
  Other NCD       \-                     1.1 (0.0-2.1)           1.6 (0.6-2.5)             19.8 (6.3-30.2)          19.7 (6.8-31.1)
  Other CD        51.2 (42.8-60.0)       1.7 (0.2-3.0)           1.0 (0.1-1.8)             7.5 (0.0-13.6)           14.5 (4.9-23.1)
  Indeterminate   25.8 (19.4-31.5)       4.8 (2.8-6.5)           20.5 (17.5-23.3)          60.3 (44.7-74.0)         173.6 (145.9-197.4)
                                                                                                                    
  **2009**        **0-4 yrs (95% CI)**   **5-14 yrs (95% CI)**   **15-49 yrs (95% CI)**    **50-64 yrs (95% CI)**   **65+ (95% CI)**
                                                                                                                    
  HIV-related     11.7 (6.2-16.7)        5.6 (3.6-7.7)           58.3 (53.9-62.3)          114.9 (94.5-137.2)       78.3 (51.7-103.4)
  MPNC            0.9 (0.0-2.1)          \-                      1.2 (0.2-2.1)             \-                       3.1 (0.0-6.2)
  Injuries        3.0 (0.0-5.7)          1.5 (0.0-2.9)           15.4 (11.7-18.9)          12.3 (1.6-20.9)          15.7 (2.6-27.0)
  Lifestyle       0.4 (0.0-0.9)          0.1 (0.0-0.2)           5.3 (3.3-7.0)             94.5 (74.9-113.8)        285.8 (249.9-322.0)
  Other NCD       \-                     \-                      1.5 (0.4-2.3)             20.6 (8.4-30.6)          29.2 (14.4-42.9)
  Other CD        45.2 (38.2-52.2)       0.8 (0.0-1.5)           1.1 (0.2-1.8)             6.2 (0.3-11.0)           9.6 (0.9-16.9)
  Indeterminate   36.1 (29.0-44.0)       2.3 (1.0-3.5)           26.9 (23.7-30.1)          89.4 (70.0-106.1)        185.6 (157.9-212.9)

![**5-14 yr Age Standardized Mortality**. (Deaths 333, Person Years Observed (PYO) 216, 005).](1478-7954-9-47-4){#F4}

The all-cause SMR for the 15-49 age group peaked at 190 (95% CI: 176, 203) deaths per 10,000 PYO in 2003 and then declined to 109 (95% CI: 100, 119) in 2009 (Figure [5](#F5){ref-type="fig"}). HIV-related mortality peaked in 2003 at 140 (95% CI: 135, 145) deaths per 10,000 PYO and then declined to 61 (95% CI: 56, 65) in 2009 (Table [3](#T3){ref-type="table"}). The CSMF for HIV-related causes declined from 74% (95% CI: 71, 78) in 2000 to 55% (95% CI: 52, 59) in 2009. This decline in HIV-related CSMF appears to be at the expense of an increase in indeterminate CSMF, which increased over the same period from 8% (95% CI: 7, 10) to 21% (95% CI: 19, 24).

![**15-49 yr Age Standardized Mortality**. (Deaths 5, 863, Person Years Observed (PYO) 387, 630).](1478-7954-9-47-5){#F5}

There was no discernible trend in all-cause mortality in the 50-64 age group (Figure [6](#F6){ref-type="fig"}). HIV-related causes constituted the largest CSMF at 42% for the entire period, followed by lifestyle-related noncommunicable diseases at 27% and indeterminate causes at 19%. There was no significant trend in HIV-related mortality and the highest mortality rates observed occurred in 2005 (180 (95% CI: 156, 206)) and 2007 (154 (95% CI: 129, 179)) after the introduction of an antiretroviral therapy (ART) program in the area in 2004 (Table [3](#T3){ref-type="table"}). Lifestyle-related noncommunicable mortality remained stable at around 88 deaths per 10,000 PYO.

![**50-64 yr Age Standardized Mortality**. (Deaths 1, 526, Person Years Observed (PYO) 47, 118).](1478-7954-9-47-6){#F6}

Age-standardized mortality in the over-65 age group appeared to increase in the early part of the decade, rising from 453 (95% CI: 377, 528) deaths per 10,000 in 2000 to a peak of 721 (95% CI: 631,812) in 2002 and plateauing off to remain stable at around 611 deaths per 10,000 PYO (Figure [7](#F7){ref-type="fig"}). Noncommunicable diseases were responsible for the largest CSMF at 50%, with lifestyle-related CSMF at 45%. Indeterminate (26%) and HIV-related (16%) causes were also important.

![**65+yr Age Standardized Mortality**. (Deaths 1, 526, Person Years Observed (PYO) 47, 118).](1478-7954-9-47-7){#F7}

Comparison of physician with InterVA coding
-------------------------------------------

There was substantial agreement (79% kappa = 0.68 (95% CI: 0.67, 0.69)) between physician coding and InterVA coding at the burden of disease group level. This agreement varied significantly among age groups (Table [4](#T4){ref-type="table"}), with the lowest agreement in the under-5 age group (kappa = 0.44 (95% CI: 0.41, 0.47)) and the over-65 age group (kappa = 0.50 (95% CI: 0.48, 0.52)), with the remaining age groups around the overall agreement level. There were no significant changes in agreement over time (Table [5](#T5){ref-type="table"}).

###### 

Agreement between physician and InterVA cause of death allocation by age group

  ---------------------------------------------------------------
  Age Group   Agreement   Kappa\                      p
                          (95% confidence interval)   
  ----------- ----------- --------------------------- -----------
  0-4         61%         0.43 (0.40-0.46)            \< 0.0001

  5-14        76%         0.68 (0.63-0.74)            \< 0.0001

  15-49       86%         0.71 (0.70-0.72)            \< 0.0001

  50-64       77%         0.68 (0.65-0.70)            \< 0.0001

  65+         68%         0.50 (0.48-0.53)            \< 0.0001

                                                      

  Overall     79%         0.68 (0.67-0.69)            \< 0.0001
  ---------------------------------------------------------------

###### 

Agreement between physician and InterVA cause of death allocation by year

  ----------------------------------------------------------
  Year   Agreement   Kappa\                      p
                     (95% confidence interval)   
  ------ ----------- --------------------------- -----------
  2000   78%         0.67 (0.64-0.70)            \< 0.0001

  2001   82%         0.72 (0.69-0.74)            \< 0.0001

  2002   82%         0.71 (0.68-0.74)            \< 0.0001

  2003   78%         0.66 (0.63-0.69)            \< 0.0001

  2004   77%         0.66 (0.63-0.69)            \< 0.0001

  2005   75%         0.63 (0.61-0.66)            \< 0.0001

  2006   76%         0.66 (0.63-0.69)            \< 0.0001

  2007   79%         0.69 (0.66-0.72)            \< 0.0001

  2008   79%         0.72 (0.69-0.75)            \< 0.0001
  ----------------------------------------------------------

Discussion
==========

Cause-specific mortality trends in the under-5 age group and the 15-49 age group were dominated by trends in HIV-related mortality in response to the introduction of interventions such as preventing mother-to-child transmission of HIV (PMTCT) and ART \[[@B7],[@B8]\]. There were no significant trends in other causes of mortality in these age groups. The CSMF for HIV-related causes for the under-5 age group (34%) for the 2002-2005 period was higher than the value (26%) reported by Byass \[[@B20]\] using InterVA (with the same set of input indicators as used by this study) for the same period in Agincourt, a demographic surveillance site in the Mpumalanga province of South Africa. In the case of the 15-49 age group, the HIV-related CSMF (72%) in this study was also higher than the value (54%) reported for the Agincourt site.

In the older age groups, HIV-related mortality remained important but showed no significant decline in the second half of the 2000-2009 period. Noncommunicable-disease mortality increased with increasing age and was the major cause of death in the 65-and-older age group. There were no clear trends in noncommunicable disease mortality over time.

The proportions of indeterminate causes in this study for the different age groups were generally lower than the levels reported by Byass \[[@B20]\] for the Agincourt site, with the exception of the under-5 age group. In the under-5 age group, 32% in this study compared to 26% in the Byass study; 21% in this study compared to 38% in the Byass study in the 5-14 age group; 12% in this study compared to 26% in the Byass study in the 15-49 age group; 17% in this study compared to 31% in the Byass study in the 50-64 age group, and 25% in this study compared to 33% in the Byass study in the 65-and-older age group.

The verbal autopsy questionnaire was not designed from inception with the InterVA input indicators in mind. A number (18 out of 106 indicators) did not map directly to the questionnaire and had to be derived indirectly. Data quality in relation to the InterVA input indicators could not be monitored on an ongoing basis and some of the changes over time in the indeterminate-cause proportion could reflect data-quality issues.

Conclusions
===========

There has been a substantial decline in proportion of deaths due to HIV-related causes in the under-5 age group over the study period coupled with a fairly constant mortality rate due to other communicable diseases and indeterminate causes. This would indicate that further gains in reducing under-5 mortality would require investigation of causes other than HIV and possibly changes in public health services. Further research is required to determine whether the resilience to change in other communicable disease mortality is due to interaction between interventions aimed at HIV and those aimed at other causes of child mortality, or due to unrelated factors.

In the 15-49 age group, the positive impact of HIV-related interventions was substantial. We did not explore sex-specific mortality, but given the different age pattern in HIV prevalence \[[@B27]\], one would expect some differences in the sex-specific HIV-related mortality trends. Although trauma mortality is dwarfed by HIV-related mortality in this age group, it is still considerably higher than the global mortality estimate \[[@B38]\].

In the older age groups, the dual burdens of communicable and noncommunicable diseases were evident. The lack of a substantial decline in HIV-related mortality in those over 50 years old requires further investigation to determine whether this was due to lack of access or response to treatment programs or an artifact of competing risks from other mortality causes.

The InterVA verbal autopsy program performed well, and the conclusions based on InterVA mortality cause allocation would have been no different had they been based on physician mortality cause allocation. The InterVA program allowed more timely analysis of cause-specific mortality; as a result we could include the 2009 deaths in this analysis in spite of the fact that physician coding is not yet complete for 2009.

Verbal autopsy based methods enabled the timely measurement of changing trends in cause-specific mortality to provide policymakers with the much-needed information to allocate resources to appropriate health interventions.
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